The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The fluciclovine (FACBC) PET/CT site-directed therapy of oligometastatic prostate cancer (Flu-BLAST-PC) trial.
 
Risa Liang Wong
No Relationships to Disclose
 
Sarah K Holt
No Relationships to Disclose
 
Jing Zeng
Honoraria - AstraZeneca; IBA
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Varian Medical Systems
 
Laura Graham
No Relationships to Disclose
 
Rachel Kang
No Relationships to Disclose
 
Nathan Conrad
No Relationships to Disclose
 
Andrea Toulouse
No Relationships to Disclose
 
Zoya Bauer
No Relationships to Disclose
 
Michael Lai
No Relationships to Disclose
 
Todd Yezefski
Consulting or Advisory Role - Dendreon
 
Jonathan L. Wright
Consulting or Advisory Role - Genzyme
Speakers' Bureau - Foundation Health Partners J. Michael Carroll Cancer Center; OncLive; seattle cancer care alliance
Research Funding - Altor BioScience; Merck; Nucleix
Other Relationship - Movember Foundation; UpToDate
 
Emily Steinberger Weg
No Relationships to Disclose
 
Andrew Caleb Hsieh
Honoraria - Hotspot Therapeutics
Patents, Royalties, Other Intellectual Property - MTOR modulators and uses thereof Patent number: 9629843; USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THERAPEUTIC TREATMENT Publication number: 20140288097
 
Heather H. Cheng
Consulting or Advisory Role - AstraZeneca (Inst)
Research Funding - Clovis Oncology (Inst); Color Genomics Foundation (Inst); Fred Hutchinson Cancer Research Center (Inst); Janssen (Inst); Sanofi (Inst)
 
Jean H Lee
No Relationships to Disclose
 
Delphine L. Chen
No Relationships to Disclose
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Dendreon
Research Funding - GenomeDx (Inst); Genomic Health (Inst); Magforce (Inst); MDxHealth (Inst)
 
Evan Y. Yu
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Bayer; Clovis Oncology; Exelixis; Janssen; Merck; Myovant Sciences; Sanofi
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Daiichi Sankyo (Inst); Dendreon (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)